We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$19.5B
AUM Growth
+$5.19B
(+36%)
Cap. Flow
+$4.12B
Cap. Flow
% of AUM
21.08%
Top 10 Holdings %
Top 10 Hldgs %
20.25%
Holding
3,398
New
1,285
Increased
656
Reduced
281
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$224M |
| 2 |
PayPal
PYPL
|
+$220M |
| 3 |
Kroger
KR
|
+$154M |
| 4 |
Zillow
Z
|
+$133M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$189M |
| 2 |
Freeport-McMoran
FCX
|
+$176M |
| 3 |
AbbVie
ABBV
|
+$171M |
| 4 |
Booking.com
BKNG
|
+$155M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 19.46% |
| 2 | Healthcare | 11.27% |
| 3 | Materials | 10.17% |
| 4 | Technology | 7.72% |
| 5 | Consumer Discretionary | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
W.R. Berkley
WRB
$28.4B
| $9.8M | 0.05% |
202,556
+201,930
| +32,257% | +$9.74M |
|
302
Stride
LRN
$4.04B
| $9.78M | 0.05% |
312,622
+98,375
| +46% | +$3.61M |
|
303
Thryv Holdings
THRY
$188M
| $9.75M | 0.05% |
513,216
+262,756
| +105% | +$5.13M |
|
304
Huntington Ingalls Industries
HII
$11.3B
| $9.71M | 0.05% |
42,083
+41,205
| +4,693% | +$9.71M |
|
305
Arthur J. Gallagher & Co
AJG
$67.1B
| $9.6M | 0.05% |
50,902
+50,474
| +11,793% | +$9.44M |
|
|
DVAX
306
DELISTED
Dynavax Technologies
DVAX
| $9.59M | 0.05% |
901,476
+246,619
| +38% | +$2.87M |
|
|
ORAN
307
DELISTED
Orange
ORAN
| $9.56M | 0.05% |
967,919
+147,780
| +18% | +$1.43M |
|
308
Equity Residential
EQR
$25.7B
| $9.43M | 0.05% |
159,796
+159,105
| +23,025% | +$9.96M |
|
309
Tesla
TSLA
$1.21T
| $9.38M | 0.05% |
76,119
-34,147
| -31% | -$6.47M |
|
310
Clearwater Paper
CLW
$289M
| $9.35M | 0.05% |
247,284
+76,640
| +45% | +$2.99M |
|
311
Corcept Therapeutics
CORT
$9.91B
| $9.31M | 0.05% |
458,469
+148,864
| +48% | +$3.73M |
|
312
Newmont
NEM
$96.6B
| $8.63M | 0.04% |
182,869
+179,082
| +4,729% | +$7.99M |
|
313
Children's Place
PLCE
$54.5M
| $8.36M | 0.04% |
229,414
+24,405
| +12% | +$913K |
|
314
STAG Industrial
STAG
$7.79B
| $8.22M | 0.04% |
254,484
-120,139
| -32% | -$3.76M |
|
315
Dorian LPG
LPG
$1.93B
| $8.08M | 0.04% |
426,201
+66,402
| +18% | +$1.19M |
|
316
Pacer Swan SOS Flex January ETF
PSFD
$58.8M
| $7.81M | 0.04% |
327,169
-7,027
| -2% | -$162K |
|
317
Medifast
MED
$108M
| $7.79M | 0.04% |
+67,568
| New | +$7.87M |
|
318
Ethan Allen Interiors
ETD
$604M
| $7.78M | 0.04% |
294,637
+101,522
| +53% | +$2.62M |
|
|
MDRX
319
DELISTED
Veradigm Inc. Common Stock
MDRX
| $7.62M | 0.04% |
432,092
+46,590
| +12% | +$781K |
|
320
CTS Corp
CTS
$1.86B
| $7.61M | 0.04% |
+192,959
| New | +$7.94M |
|
321
Pacer Swan SOS Flex April ETF
PSFM
$25.3M
| $7.59M | 0.04% |
345,763
-15,765
| -4% | -$340K |
|
322
Ligand Pharmaceuticals
LGND
$5.93B
| $7.49M | 0.04% |
+112,105
| New | +$7.29M |
|
323
Broadcom
AVGO
$1.81T
| $7.46M | 0.04% |
133,510
-146,010
| -52% | -$7.32M |
|
324
Pacer Swan SOS Flex July ETF
PSFJ
$44.7M
| $7.42M | 0.04% |
355,121
-7,759
| -2% | -$161K |
|
325
Pacer Swan SOS Flex October ETF
PSFO
$38.1M
| $7.28M | 0.04% |
337,582
-7,212
| -2% | -$154K |
|
Similar funds
SAM
Pacer Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Pacer Advisors held 3,398 positions worth $19.5B, up 36% from $14.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Pacer Advisors deployed $4.12B of net new capital in Q4 2022, opening 1,285 new positions and adding to 656 existing holdings. Its largest new stake was Woodside Energy: 805,273 shares worth $19.5M.
By sector, the portfolio is most concentrated in Energy at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $189M trimmed.
- Pacer Advisors's largest Q4 2022 buy was Woodside Energy: 805,273 shares worth $19.5M.
- Pacer Advisors added most to EOG Resources in Q4 2022, an estimated $224M increase.
- Pacer Advisors's biggest Q4 2022 reduction was Regeneron Pharmaceuticals, cutting an estimated $189M.
- Pacer Advisors fully exited Rithm Capital in Q4 2022, selling an estimated $118M.
- Pacer Advisors's ten largest holdings make up 20% of its $19.5B portfolio in Q4 2022.
- Pacer Advisors opened 1,285 new positions and closed 56 in Q4 2022.
- Pacer Advisors's portfolio value rose 36% quarter-over-quarter to $19.5B.
Based on Pacer Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.